Animal Placental Protein Market By Source (Cattle Placenta, Sheep Placenta, Horse Placenta, Pig Placenta), By Type (Placental Extracts, Placental Proteins), By Form (Powder, Liquid), By Application (Healthcare and Pharmaceuticals, Cosmetics and Personal Care, Nutraceuticals and Supplements, Veterinary Medicine), By End-User (Pharmaceutical Companies, Cosmetic Manufacturers, Nutraceutical Manufacturers, Veterinary Care Providers, Research Institutions), and By Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Animal Placental Protein Market was valued at USD 1.1 billion in 2023 and will surpass USD 2.6 billion by 2030; growing at a CAGR of 13.2% during 2024 - 2030.

The animal placental protein market is gaining significant traction due to the growing recognition of the therapeutic and cosmetic benefits of placental extracts and proteins. Sourced from various animals, including cattle, sheep, and horses, these proteins are rich in essential nutrients, growth factors, and bioactive compounds, making them valuable in healthcare, cosmetics, nutraceuticals, and veterinary medicine. The market is segmented by source, type, form, application, and end-user, each contributing to the dynamic growth of the industry. As demand increases for natural and biologically active ingredients, the market for animal placental proteins is expected to continue expanding across multiple sectors, from pharmaceuticals to cosmetics.

Cattle Placenta Source Is Largest Due to Abundant Supply and Nutritional Value

Among the various sources of animal placental proteins, cattle placenta holds the largest share of the market. Cattle are one of the most common animals used for placental protein extraction due to their large size and the relatively high yield of placenta tissue. Cattle placental proteins are rich in essential amino acids, growth factors, and vitamins, making them highly sought after in the healthcare and cosmetics industries. The abundance of cattle farming across the world further contributes to the widespread availability of cattle placenta, ensuring a steady supply of raw material for the production of placental extracts and proteins.

Cattle placenta is also favored for its potential benefits in skin regeneration, anti-aging treatments, and overall health improvement. The high nutrient content of cattle placental proteins is utilized in numerous products, including cosmetic formulations aimed at skin rejuvenation and anti-wrinkle treatments. As the demand for effective natural ingredients continues to rise, the cattle placenta segment is expected to maintain its dominant position in the market.

Placental Extracts Are Fastest Growing Due to Their Versatile Applications

Placental extracts are the fastest growing sub-segment in the market, driven by their versatility and wide range of applications across industries. These extracts contain a mixture of proteins, enzymes, growth factors, and hormones, which are known to have therapeutic, anti-inflammatory, and regenerative properties. As a result, they are increasingly used in healthcare and pharmaceutical products aimed at improving skin health, promoting wound healing, and even in treatments for chronic conditions.

The growing trend of using natural and bioactive compounds in skincare and wellness products is fueling the demand for placental extracts, particularly in the cosmetics and nutraceuticals industries. In addition to their effectiveness in skin care, placental extracts are also being explored for their potential use in pharmaceuticals for their regenerative and anti-aging properties. This expanding application base is expected to drive rapid growth in the placental extracts segment, making it the fastest growing in the animal placental protein market.

Powder Form Is Largest Due to Easier Handling and Storage

In the form category, powder is the largest sub-segment in the animal placental protein market. Powdered placental proteins and extracts are favored due to their convenience in handling, storage, and transportation. The powder form allows for better preservation of the active compounds found in placental proteins and extends the shelf life of the product. This is particularly important in the production of nutraceuticals, where stability and long-term usability are crucial.

Powdered placental products are also more easily incorporated into various formulations, such as dietary supplements, cosmetics, and pharmaceutical products. Additionally, they offer a higher degree of flexibility in dosing and blending with other ingredients, making them a popular choice for manufacturers. As demand for placental-based products continues to rise, the powder form will remain dominant due to its practical advantages in production and distribution.

Healthcare and Pharmaceuticals Application Is Largest Due to Therapeutic Benefits

In the application segment, healthcare and pharmaceuticals represent the largest and most lucrative sub-segment in the animal placental protein market. Placental proteins, especially those derived from cattle and sheep placentas, have long been studied for their regenerative, anti-inflammatory, and growth-promoting properties, making them highly valuable in therapeutic applications. These proteins are used in the development of wound healing products, anti-aging treatments, and even in advanced therapies for chronic diseases like arthritis and diabetes.

The increasing interest in biologically active, natural ingredients for medical treatments has driven the growth of this segment. Placental proteins are also being explored in more innovative areas, such as cell regeneration therapies and stem cell treatments, which further contribute to their prominence in the healthcare and pharmaceutical industries. As research advances and the therapeutic potential of placental proteins is better understood, the healthcare application segment will continue to lead the market.

Pharmaceutical Companies End-User Segment Is Largest Due to Growing Demand for Therapeutic Products

The pharmaceutical companies end-user segment is the largest in the animal placental protein market, reflecting the growing demand for therapeutic products derived from placental proteins. Pharmaceutical companies utilize placental proteins in the development of advanced wound care treatments, regenerative medicine, and even in the formulation of drugs that target specific conditions related to skin aging, inflammation, and tissue repair. The increasing recognition of the regenerative properties of placental proteins has contributed to their incorporation into a wide range of medical products.

The market for placental protein-based pharmaceuticals is further bolstered by the rising global demand for natural and effective treatment options. As pharmaceutical companies continue to focus on developing biologic treatments, the need for high-quality placental extracts and proteins will continue to grow, positioning pharmaceutical companies as the leading end-users in this market. Their significant investment in research and development will also help drive the continued expansion of the animal placental protein market.

Asia Pacific Is Fastest Growing Region Due to Rising Demand in Cosmetics and Healthcare

Asia Pacific is the fastest growing region in the animal placental protein market, driven by the rapidly expanding cosmetics and healthcare industries. Countries like Japan, South Korea, and China have become major markets for beauty and personal care products, with consumers increasingly seeking natural and biologically active ingredients, such as placental proteins, for skincare and anti-aging solutions. The region’s large and growing population, along with a rising middle class with higher disposable income, is also fueling the demand for high-quality healthcare products that incorporate placental proteins.

In addition to the cosmetics industry, Asia Pacific is experiencing growth in the nutraceutical and pharmaceutical sectors, where placental proteins are being explored for their therapeutic benefits. The increasing awareness of the benefits of placental-based treatments in managing conditions such as skin aging, joint inflammation, and tissue repair is driving this growth. With an expanding market and a strong focus on innovation, Asia Pacific is poised to be the fastest growing region for animal placental proteins.

Leading Companies & Competitive Landscape

The animal placental protein market is highly competitive, with several key players leading the industry. Major companies such as DHG Pharmaceuticals, Fidia Farmaceutici, and Medivie Therapeutic, along with numerous regional players, dominate the market. These companies focus on advancing their research and development efforts to explore new therapeutic applications for placental proteins, such as wound healing, regenerative medicine, and anti-aging treatments.

The competitive landscape is characterized by the ongoing innovation in placental protein formulations, including the development of combination products and new delivery methods that enhance bioavailability and effectiveness. Companies are also exploring collaborations with research institutions and cosmetic manufacturers to expand their product portfolios and enter new markets. As the demand for natural, effective ingredients in the healthcare and cosmetics sectors continues to rise, the competition within the animal placental protein market is expected to intensify, driving further product innovation and market expansion.

Recent Developments:

• Health & Beauty Natural Oils introduced a new line of placenta-derived extracts aimed at enhancing skin regeneration for cosmetic products.
• Lonza Group expanded its portfolio of animal placental proteins for use in medical treatments, focusing on wound healing and tissue regeneration.
• Ferring Pharmaceuticals announced the launch of a new pharmaceutical product that uses animal placental proteins for improving fertility treatments.
• Shanghai Taiwei Pharmaceutical received regulatory approval for its new placenta-based nutraceutical supplement, promoting skin health and vitality.
• BioProducts Laboratory Ltd. entered into a partnership with cosmetic manufacturers to supply placental protein extracts for use in anti-aging skin care formulations.
•  

List of Leading Companies:

• The Greenfield Group
• Health & Beauty Natural Oils
• Laboratoire Bio-Planète
• Groupe Berkem
• Institut Biotech Marine
• BioProducts Laboratory Ltd.
• Shanghai Taiwei Pharmaceutical Co. Ltd.
• Plantae Group
• Polaris Laboratories
• Ferring Pharmaceuticals
• Hubei Shuangliu Pharmaceutical Co. Ltd.
• Alp Pharma Inc.
• Daewoong Pharmaceutical Co. Ltd.
• MediWound Ltd.
• Lonza Group

Report Scope: